BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18558091)

  • 1. Constitutive CXCL12 expression induces anoikis in colorectal carcinoma cells.
    Wendt MK; Drury LJ; Vongsa RA; Dwinell MB
    Gastroenterology; 2008 Aug; 135(2):508-17. PubMed ID: 18558091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL12 chemokine expression and secretion regulates colorectal carcinoma cell anoikis through Bim-mediated intrinsic apoptosis.
    Drury LJ; Wendt MK; Dwinell MB
    PLoS One; 2010 Sep; 5(9):e12895. PubMed ID: 20877573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK.
    Kamarajan P; Kapila YL
    Apoptosis; 2007 Dec; 12(12):2221-31. PubMed ID: 17879163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis.
    Wendt MK; Johanesen PA; Kang-Decker N; Binion DG; Shah V; Dwinell MB
    Oncogene; 2006 Aug; 25(36):4986-97. PubMed ID: 16568088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AEG-1 promotes anoikis resistance and orientation chemotaxis in hepatocellular carcinoma cells.
    Zhou Z; Deng H; Yan W; Luo M; Tu W; Xia Y; He J; Han P; Fu Y; Tian D
    PLoS One; 2014; 9(6):e100372. PubMed ID: 24941119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
    Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH
    J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2.
    Jørgensen K; Skrede M; Cruciani V; Mikalsen SO; Slipicevic A; Flørenes VA
    Biochem Biophys Res Commun; 2005 Apr; 329(1):266-74. PubMed ID: 15721302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
    Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
    J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buddlejasaponin IV induces apoptotic cell death by activating the mitochondrial‑dependent apoptotic pathway and reducing α
    Kim JE; Lee SK; Park J; Jung MJ; An SE; Yang HJ; Chung WY
    Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36799199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways.
    Shen X; Artinyan A; Jackson D; Thomas RM; Lowy AM; Kim J
    Pancreas; 2010 Jan; 39(1):81-7. PubMed ID: 19820417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway.
    Fukazawa H; Noguchi K; Murakami Y; Uehara Y
    Mol Cancer Ther; 2002 Mar; 1(5):303-9. PubMed ID: 12489846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway.
    Tan CT; Chu CY; Lu YC; Chang CC; Lin BR; Wu HH; Liu HL; Cha ST; Prakash E; Ko JY; Kuo ML
    Carcinogenesis; 2008 Aug; 29(8):1519-27. PubMed ID: 18487224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells.
    Wendt MK; Cooper AN; Dwinell MB
    Oncogene; 2008 Feb; 27(10):1461-71. PubMed ID: 17724466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anchorage-independent phosphorylation of p130(Cas) protects lung adenocarcinoma cells from anoikis.
    Wei L; Yang Y; Zhang X; Yu Q
    J Cell Biochem; 2002; 87(4):439-49. PubMed ID: 12397603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis.
    Roy I; Zimmerman NP; Mackinnon AC; Tsai S; Evans DB; Dwinell MB
    PLoS One; 2014; 9(3):e90400. PubMed ID: 24594697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cancer.
    Johnson TR; Khandrika L; Kumar B; Venezia S; Koul S; Chandhoke R; Maroni P; Donohue R; Meacham RB; Koul HK
    Mol Cancer Res; 2008 Oct; 6(10):1639-48. PubMed ID: 18922979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular signal-regulated kinase activation during renal ischemia/reperfusion mediates focal adhesion dissolution and renal injury.
    Alderliesten M; de Graauw M; Oldenampsen J; Qin Y; Pont C; van Buren L; van de Water B
    Am J Pathol; 2007 Aug; 171(2):452-62. PubMed ID: 17620366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of adhesion triggers differential FAK and SAPKp38 signals in SW620 human colon cancer cells that may inhibit adhesiveness and lead to cell death.
    Walsh MF; Thamilselvan V; Grotelueschen R; Farhana L; Basson M
    Cell Physiol Biochem; 2003; 13(3):135-46. PubMed ID: 12876384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells.
    Uehara N; Matsuoka Y; Tsubura A
    Mol Cancer Res; 2008 Feb; 6(2):186-93. PubMed ID: 18245228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorpyrifos promotes colorectal adenocarcinoma H508 cell growth through the activation of EGFR/ERK1/2 signaling pathway but not cholinergic pathway.
    Suriyo T; Tachachartvanich P; Visitnonthachai D; Watcharasit P; Satayavivad J
    Toxicology; 2015 Dec; 338():117-29. PubMed ID: 26514924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.